Every minute counts in cardiology—but for too many patients, the wait to see a specialist is measured in weeks.
In this episode of Med Tech Gurus, Dr. Jeff Wessler, cardiologist and CEO of Heartbeat …
Published on 7 hours ago
When it comes to serious illness, early detection can be the difference between a difficult battle and a manageable path forward. But what if advanced diagnostics didn't require a referral, radiation…
Published on 1 week ago
What if diagnosing coronary artery disease, pulmonary hypertension, and heart failure didn't require a hospital, a specialist, or even invasive testing?
In this episode, Adrian Lam, CEO of Corvista H…
Published on 2 weeks ago
What if a discreet sensor could quietly prevent one of healthcare's most common—and dangerous—IV injuries?
In this episode of Med Tech Gurus, Jaclyn Lautz Ph.D., COO of IV Watch, takes us inside the …
Published on 3 weeks ago
What if a simple design shift could save lives in the most chaotic environments?
In this episode of Med Tech Gurus, Dr. Irena King, neuroscientist, engineer, and CEO of Surgicure Technologies, shares…
Published on 4 weeks ago
What if the key to fixing pharma's toughest challenges wasn't more complexity—but more clarity?
In this episode of Med Tech Gurus, Shetal Vyas, SVP of Commercial Strategy & Development at Ardelyx, jo…
Published on 1 month ago
What if we could detect Alzheimer's disease before the first memory fades?
In this powerful episode of Med Tech Gurus, Dr. Maria-Magdalena Patru, MD, PhD—who leads the neurology medical team at Roche…
Published on 1 month, 1 week ago
What if the future of clinical trials wasn't just faster—but dramatically more human-centered, efficient, and aligned with real-world outcomes? In this episode of Med Tech Gurus, Meri Beckwith, co-fo…
Published on 1 month, 2 weeks ago
What if you could cut your product development time in half—and avoid the regulatory landmines that derail most startups? In this episode of Med Tech Gurus, Marcel Botha, CEO and Founder of 10XBeta, …
Published on 1 month, 3 weeks ago
What happens when clinical strategy, bioinformatics, and market access all live under one roof? Meet Tyler O'Malley, VP at Exagen, who shares how this rare triad is driving innovation in autoimmune d…
Published on 2 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate